Neuro-Infectious Diseases Group

 

Aaron M. Calrson, MD

Dr. Carlson is an Assistant Professor in the Department of Neurology. His clinical interest lies at the intersection of hospital neurology, autoimmune neurology, and neuro-infectious diseases. He completed neurology residency at UCLA, and a fellowship in Neuroimmunology and Multiple Sclerosis at Stanford University. He is active in medical education at multiple levels, and his research focuses on epidemiology and real-world treatment of uncommon and rare neuroimmunological diseases, with the ultimate goal of understanding and optimizing evaluation and treatment at the population level.

Lakshmi Chauhan, MD

 

Dr. Chauhan is an Assistant Professor in Infectious Diseases and her clinical focus includes HIV, neuroinfectious disease and global health. She completed her residency training at University of Tennessee, Memphis and Infectious disease fellowship at University of Colorado, Denver. She has worked in different parts in Asia including India and Nepal. She has extensive clinical experience in different types of infectious diseases including tropical infections. She has been involved in quality improvement projects on antimicrobial stewardship. More recently, her focus has been on understanding factors for disease severity and clinical therapeutic trials in COVID-19. Dr. Chauhan also serves as an associate program director for the Neuro-Infectious Diseases/Autoimmune Neurology Fellowship, providing the fellow with additional training in the diagnostic work up and management of infectious diseases.

Ryan Kammeyer, MD

Dr. Kammeyer is an Assistant Professor of Neurology and Pediatrics, and sees both adult and pediatric patients. His research interests include improving the differentiation of autoimmune and infectious encephalitis through clinical features, evaluation of biomarkers of disease activity in autoimmune encephalitis (with Dr. Piquet), and evaluation of neuro-rheumatologic diseases such as neuropsychiatric lupus, with a goal of improving diagnosis, prevention, and treatment of these rare diseases. He is also researching neuropsychological and socioeconomic outcomes in pediatric onset multiple sclerosis (with Dr. Schreiner), and evaluation and treatment of regression in patients with Down syndrome (with the Crnic Institute).

Elizabeth Matthews, MD

Dr. Matthews is an Assistant Professor of Neurology and works as a full-time neurohospitalist. She completed residency training at New York-Presbyterian Hospital - Columbia University where she was selected to do a dedicated PGY5 Chief Resident year. She is a graduate of the University of Colorado Neuroinfectious Diseases/Autoimmune Neurology Fellowship and thrilled to be staying on as a faculty member. Her clinical interests include the acute work-up and management of neuroinfectious and neuroinflammatory disorders in the inpatient setting. She also has a passion for medical education and has won several awards in this area including the "The Neurological Institute Dedication to Excellence in Teaching Award" in 2020. 

Kevin Messacar, MD

 

Dr. Messacar is a pediatric infectious disease physician and researcher who focuses on improving and implementing new diagnostic tests for central nervous system infections. He is currently studying the implementation and impact of rapid multiplex PCR panels and next-generation sequencing platforms for infectious pathogens in cerebrospinal fluid. Since 2014, Dr. Messacar has been involved in investigations of the polio-like illness, acute flaccid myelitis, including its relationship to the emerging respiratory virus, enterovirus D68. Clinically, he provides specialty consultation for children with meningitis, encephalitis, and myelitis at Children’s Hospital Colorado.

Maria A. Nagel, MD

 

Dr. Nagel specializes in neurological complications of varicella zoster virus (VZV) and herpes simplex virus, including postherpetic neuralgia, stroke, giant cell arteritis and burning mouth syndrome. She received her clinical neurology training at the University of Colorado and her basic research training at the University of Chicago (tumor immunology, Dr. Hans Schreiber), University of Illinois (mRNA regulation, Dr. David Shapiro) and University of Colorado (VZV pathogenesis, Dr. Don Gilden). Her laboratory studies the mechanisms by which VZV infects intracranial and extracranial arteries to produce stroke, giant cell arteritis and granulomatous aortitis using human biopsy samples, primary human vascular cells and a unique human artery explant model. Of particular interest is how cytokines, matrix metalloproteinases, reactive oxygen species and programmed death ligand-1 contribute to persistent vascular inflammation and damage to the artery. Her lab also focuses on novel antiviral therapies that target purinergic receptors and metabolic components necessary for virus replication, as well as on antiviral lipid nanoparticle therapy to inhibit hematogenous spread of virus and dissemination to multiple organs.

Daniel M. Pastula, MD, MHS

 

Dr. Pastula is a neurologist, CDC-trained medical epidemiologist (EIS), and veteran of the U.S. Public Health Service with interests in neurohospitalist medicine, neuro-infectious and emerging infectious diseases, public health and epidemiology, outbreak investigation and control, and global health. He frequently collaborates with public health institutions such as the Colorado Department of Public Health and Environment (CDPHE) and the U.S. Centers for Disease Control and Prevention (CDC). As a neurohospitalist, he primarily sees hospitalized inpatients for a variety of acute neurologic emergencies. He currently serves as the program director for the Neuro-Infectious Diseases/Autoimmune Neurology Fellowship and section chief of the Neuro-Infectious Diseases and Global Neurology Section.

 

 

Amanda L. Piquet, MD

 

Dr. Piquet is an Assistant Professor of Neurology and her clinical focus includes Neuroimmunology and Neuroinfectious disease. She completed her residency training at the Harvard Medical School’s program at Massachusetts General Hospital and Brigham and Women’s hospital in Boston. After residency, Dr. Piquet traveled to Salt Lake City for fellowship training in Autoimmune Neurology at the University of Utah. Her research and clinical interests include encephalitis, both autoimmune and infectious etiologies. She has is involved with quality improvement projects focused on the diagnosis and management of patients with acute encephalitis. Dr. Piquet also serves as an associate program director for the Neuro-Infectious Diseases/Autoimmune Neurology Fellowship, providing the fellow with additional training in the diagnostic work up and management of neuro-inflammatory diseases and autoimmune neurology. This includes patients with antibody-mediated disorders of the nervous system including autoimmune encephalitis, NMO, stiff-person syndrome, demyelinating disease, vasculitis, neurosarcoidosis and CNS complications of rheumatological disease, among others.

Teri Schreiner, MD, MPH

 

Dr. Schreiner is an Associate Professor of Neurology and Pediatrics. She comes to her interest in Neuroimmunology and Neuroinfectious disease by a circuitous route. She received a BA in Anthropology from the University of Pennsylvania, a Masters of Public Health from Yale University and several years of working in healthcare consulting before going to medical school at the University of Rochester. She has been in Colorado, the University of Colorado and Children's Hospital Colorado, for 11 years. She was very closely involved in the acute flaccid myelitis cluster of cases that presented in the context of an Enterovirus D68 outbreak in 2014. Recent efforts have included characterizing the 12 month outcomes of the children affected with AFM in 2014. She has lectured nationally on this topic and served as an international resource for providers with similar patients.

Anna Shah, MD

Dr. Shah is an assistant professor of neurology at the University of Colorado School of Medicine. She completed neurology residency and chief resident year at the University of Michigan and then completed Neuroimmunology / Multiple Sclerosis fellowship at the University of Colorado. She currently serves as the Associate Director for Outpatient Neurology at the University of Colorado Hospitals as well as the Director of Outpatient Patient Safety and Experience. She primarily sees individuals with inflammatory or autoimmune diseases of the brain and spine. Her clinical interests include optimization of immunosuppressants in individuals with neuroinflammatory diseases, including minimization of infectious complications. Her specific research interests lie at the intersection of women’s health in neuroinflammatory diseases, including pregnancy and lactation, as well as both medical and patient education.

 

Kenneth L. Tyler, MD

 

Dr. Tyler is the Louise Baum Endowed Chair and Chairman of the Department of Neurology, and Professor of Medicine (Infectious Diseases) and Immunology-Microbiology. He trained in Internal Medicine at the Brigham and Neurology at MGH, followed by a postdoctoral fellowship with the late Dr. Bernard Fields in Microbiology and Molecular Genetics at Harvard Medical School. His laboratory uses a variety of neurotropic viruses, including reoviruses, Enterovirus D-68, and Flaviviruses (West Nile, Japanese encephalitis and Zika) to study the pathogenesis of viral CNS infections. A particular interest has been in understanding the nature of specific cellular pathways (signaling, gene expression, apoptosis) that are activated during neurotropic viral infections and that lead to neuronal injury and death. The laboratory uses primary cell cultures, ex vivo slice cultures of brain and spinal cord, and murine models to study virus-cell interactions. Recent studies have involved mapping transcription factor regulated gene expression pathways in brains of virally infected animals, defining virus-induced apoptotic signaling pathways, and examining the role of neuroinflammation (chemokine and cytokine expression, microglial and astrocyte activation) in neuronal death and CNS tissue injury. Dr. Tyler has been extensively involved in clinical studies related to PML and JC virus infection, WNV neuroinvasive disease, acute flaccid myelitis associated with Enterovirus D-68 infection, and in the studies of the use of CSF PCR and NextGen sequencing techniques in the diagnosis of CNS viral infections.

Andrew B. Wolf, MD

Dr. Wolf is an Assistant Professor of Neurology at the University of Colorado School of Medicine where he also completed medical school, neurology residency, and neuroimmunology fellowship. His clinical practice is focused on inflammatory diseases of the central nervous system, including multiple sclerosis (MS) and other demyelinating diseases. His primary research interests are optimizing the selection, sequencing, and safety of disease-modifying therapies (DMTs) for multiple sclerosis. Specific interests include evaluating alternative dosing regimens and reducing infectious complications for patients on anti-CD20 DMTs. He maintains an active interest in resident and fellow education and currently serves as faculty director for the neurology residency’s journal club.